OasisLMS

Explore the complexities of thoracic cancer care through interactive, case-based simulations that reflect real-world clinical challenges. Designed primarily for professionals and trainees in radiation oncology, thoracic surgery, pulmonology, and pathology, the series also offers valuable insights for the broader multidisciplinary care team. Each virtual patient scenario invites learners to apply evidence-based strategies, strengthen clinical decision-making, and navigate key diagnostic and treatment considerations. Developed by global thoracic oncology experts, this series supports collaborative practice and the delivery of high-quality, multidisciplinary care across diverse clinical settings.

This series includes four case-based simulations:

1. Radiation Oncology –"Marcel"– I have had a bit of shortness of breath on exertion for years, but otherwise I feel fine. They found a growing spot on my lung and told me surgery would be too dangerous for my breathing. What does this treatment mean for me?
2. Pathology – "Minato" – Although I have no symptoms, what do we need to do about my lung cancer? Do I need to worry that it will kill me?
3. Pulmonology – "Matthew" – I have had a dry cough for 2 months, and when I go up 2 sets of stairs, I get breathless. So I went to my family doctor and he asked me to do a CT scan. I am very concerned with the CT report.
4. Thoracic Surgery – "Judy" – I have had a persistent cough for the past month, and it gets especially bad when I do some physical activity. I would like to know what is causing it. And whatever it turns out to be, I would rather understand my choices than just be told what is going to happen.

This activity is designed for multidisciplinary teams of medical oncologists, surgical oncologists, pathologists, histologists, clinical radiation oncologists, pulmonologists, radiologists and interventional radiologists, translational scientists, nurses, nurse practitioners, scientists, specialty pharmacists and physician assistants globally.

Upon, completion of this activity, the participants should be able to:

• Recognize diagnostic and therapeutic challenges faced by radiation oncologists, thoracic surgeons, pulmonologists and pathologists in the management of thoracic malignancies.
• Discuss multidisciplinary approaches for the management of thoracic cancer across different histologies and stages.
• Illustrate differences in diagnostic and treatment approaches across specialties and clinical settings.

Case Authors and Co-Authors

• Radiation Oncology
  • Houda Bahig, Centre Hospitalier de l'Université de Montréal, Quebec, Canada
  • Alex Louie, Sunnybrook Health Sciences Centre, Ontario, Canada 
  • Shankar Siva, Peter MacCallum Cancer Centre, Victoria, Australia 
• Pulmonology
  
  • Telma Sequira, Instituto Portugues de Oncologia de Lisboa Francisco Gentil Martins, Lisbon, Portugal
  • António Bugalho, CUF Tejo Hospital, Lisbon, Portugal
• Pathology
  • Yuko Minami, Ibaraki Higashi National Hospital,  Naka District, Ibaraki, Japan
  • Anja Roden, Mayo Clinic Rochester, Minnesota, USA
• Thoracic Surgery 
  • Calvin Ng, Chinese University of Hong Kong, Hong Kong
  • Clarence Chan, Chinese University of Hong Kong, Hong Kong

Reviewing Committee

• Telma Sequira, Instituto Portugues de Oncologia de Lisboa Francisco Gentil Martins, Lisbon, Portugal
• Sheena Bhalla, University of Texas Southwestern Medical Center, Texas, USA
• Pranshu Mohindra, University Hospitals Seidman Cancer Center, Ohio, USA
• Tracy Leong, Austin Hospital, Heidelberg, Australia
• Tom Newsom-Davis, Chelsea and Westminster Hospital, London, UK
• Ross Soo, National University Cancer Institute, Singapore
• Fernando Lopez-Rios, Hospital Universitario HM Sanchinarro, Madrid, Spain 
• Whitney Lewis, The University of Texas MD Anderson Cancer Center, Texas, USA
• Morten Quist, University Hospital Copenhagen, Copenhagen, Denmark
• Rudolf Huber, Ludwig-Maximilians-University of Munich, Munich, Germany
• Long Jiang, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
• Merel Hennink, Longkanker Nederland, Utrecht, Netherlands
• John Cannings, Rare Cancers Australia, New South Wales, Australia
• Gustavo Faibischew Prado, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.